Not all effector CD8+ T cells are alike

Microbes and Infection

Volumn 5, Issue 3, 2003, Pages 199-204

  Drake III, Donald R ^a   Braciale, Thomas J ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Effector CD8+ T cells; MHC

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

ANTIGEN PRESENTING CELL; CELL HETEROGENEITY; CELL SPECIFICITY; CELL TRANSFORMATION; EFFECTOR CELL; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0037349387     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00011-X     Document Type: Review

References (70)

1. Monks C.R.F., Freiberg B.A., Kupfer H., Sciaky N., Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:1998;82-86.
2. Dustin M.L., Shaw A.S. Costimulation: building an immunological synapse. Science. 283:1999;649-650.
3. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synpase: a molecular machine controlling T cell activation. Science. 285:1999;221-227.
4. Paul W.E., Seder R.A. Lymphocyte responses and cytokines. Cell. 76:1994;241-251.
5. Viola A., Schroeder S., Sakakibara Y., Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 283:1999;680-682.
6. Moran M., Miceli M.C. Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: a role for lipid rafts in T cell activation. Immunity. 9:(6):1998;787-796.
7. Montixi C., Langlet C., Bernard A.M., Thimonier J., Dubois C., Wurbel M.A., Chauvin J.P., Pierres M., He H.T. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. Embo. J. 17:1998;5334-5348.
8. Xavier R., Brennan T., Li Q., McCormack C., Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity. 8:1998;723-732.
9. Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P., Samelson L.E. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell. 92:1998;83-92.
10. Yashiro-Ohtani Y., Zhou X.Y., Toyo-Oka K., Tai X.G., Park C.S., Hamaoka T., Abe R., Miyake K., Fujiwara H. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts. J. Immunol. 164:2000;1251-1259.
11. Brdicka T., Cerny J., Horejsi V. T cell receptor signaling results in rapid tyrosine phosphorylation of the linker protein LAT present in detergent-resistant membrane microdomains. Biochem. Biophys. Res. Commun. 248:1998;356-360.
12. Janes P.W., Ley S.C., Magee A.I. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J. Cell Biol. 147:1999;447-461.
13. + T cells. J. Immunol. 166:2001;7009-7013.
14. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Mol. Cell Biol. 1:2000;31-39.
15. Geiger B., Rosen D., Berke G. Spatial relationships of microtubule-organizing centers and the contact area of cytotoxic T lymphocytes and target cells. J. Cell Biol. 95:1982;137-143.
16. Kupfer A., Swain S.L., Singer S.J. The specific direct interaction of helper T cells and antigen-presenting B cells. II. Reorientation of the microtubule organizing center and reorganization of the membrane-associated cytoskeleton inside the bound helper T cells. J. Exp. M. 165:1987;1565-1580.
17. Wulfing C., Davis M.M. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science. 282:1998;2266-2269.
18. Wulfing C., Sjaastad M.D., Davis M.M. Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc. Natl. Acad. Sci. USA. 95:1998;6302-6307.
19. Valitutti S., Dessing M., Aktories K., Gallati H., Lanzavecchia A. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J. Exp. M. 181:1995;577-584.
20. Dustin M.L., Olszowy M.W., Holdorf A.D., Li J., Bromley S., Desai N., Widder P., Rosenberger F., vander Merwe P.A., Allen P.M., Shaw A.S. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell. 94:1998;667-677.
21. Rozdzial M.M., Malissen B., Finkel T.H. Tyrosine phosphorylated T cell receptor zeta chain associates with the actin cytoskeleton upon activation of mature T lymphocytes. Immunity. 3:1995;623-633.
22. Offringa R., Bierer B.E. Association of CD2 with tubulin. Evidence for a role of the cytoskeleton in T cell activation. J. Biol. Chem. 268:1993;4979-4988.
23. Sedwick C.E., Morgan M.M., Jusino L., Cannon J.L., Miller J., Burkhardt J.K. TCR, LFA-1, and CD28 play unique and complementary roles in signaling T cell cytoskeletal reorganization. J. Immunol. 162:1999;1367-1375.
24. Heusel J.W., Wesselschmidt R.L., Shresta S., Russell J.H., Ley T.J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 76:1999;977-987.
25. Berke G. The CTL's kiss of death. Cell. 81:1995;9-12.
26. + T cells to intracellular bacteria. Curr. Opin. Immunol. 11:1999;89-93.
27. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. M. 177:1993;1791-1796.
28. Linsley P.S., Ledbetter J.A. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:1993;191.
29. Liu Y., Linsley P.S. Costimulation of T-cell growth. Curr. Opin. Immunol. 4:1992;265-270.
30. Jenkins M.K., Schwartz R.H. Antigen presentation by chemicallymodified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. M. 165:1987;302.
31. Harding F., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. CD28 mediated signaling costimulates murine T cells and prevents the induction of anergy in T cell clones. Nature. 356:1992;607.
32. Schoenberger S.P., Toes R.E.M., van der Voort E.I.H., Offringa R., Melief C.J.M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:1998;480-483.
33. + T-helper and a T-killer cell. Nature. 393:1998;474-478.
34. Bennett S.R.M., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F.A.P., Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:1998;478-480.
35. French R.R., Chan H.T., Tutt A.L., Glennie M.J. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat. M. 5:1999;548-553.
36. Albert M., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998;86-89.
37. Iezzi G., Karjalainen K., Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity. 8:1998;89-95.
38. Opferman J.T., Ober B.T., Ashton-Rickardt P.G. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science. 283:(5408):1999;1745-1748.
39. Oehen S., Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161:1998;5338-5346.
40. van Stipdonk M.J.B., Lemmens E.E., Schoenberger S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:2001;423-429.
41. Kaech S.M., Ahmed R., Memory C.D. T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:2001;415-422.
42. Evavold B.D., Sloan-Lancaster J., Wilson K.J., Rothbard J.B., Allen P.M. Specific cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity. 2:1995;655-663.
43. Evavold B.D., Sloan-Lancaster J., Hsu B.L., Allen P.M. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:1993;3131-3140.
44. + T cells by a self-derived peptide. Nature. 378:(6554):1995;295-298.
45. Sloan-Lancaster J., Allen P.M. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 7:(1):1995;103-109.
46. Moss P.A., Rowland-Jones S.L., Frodsham P.M., McAdam S., Giangrande P., McMichael A.J., Bell J.I. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci. USA. 92:1995;5773-5777.
47. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D., Zajac A., Miller J., Slansky J., Ahmed J. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
48. + memory T cells. J. Exp. M. 186:1997;859-865.
49. Altman J.D., Moss P., Goulder P., Barouch D.H., McHeyzer W.M., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigenic-specific T lymphocytes. Science. 274:1996;94-96.
50. + T cells in vivo during infection and tumor rejection. J. Immunol. 163:1999;3369-3378.
51. Doherty P.C., Christensen J.P. Accessing complexity: the dynamics of virus-specific T cell responses. Annu. Rev. Immunol. 18:2000;561-592.
52. + T cells with a defect in effector function that is reversible on extended IL-2 incubation. J. Virol. 75:2001;3028-3033.
53. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J., Suresh M., Altman J.D., Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. M. 188:(12):1998;2205-2213. (see comments).
54. Appay V., Nixon D.F., Donahoe S.M., Gillespie G.M., Dong T., King A., Ogg G.S., Spiegel H.M., Conlon C., Spina C.A., Havlir D.V., Richman D.D., Waters A., Easterbrook P., McMichael A.J., Rowland-Jones S.L. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. M. 192:(1):2000;63-75.
55. + T cells specific to a single viral epitope. J. Immunol. 165:2000;6214-6220.
56. Speiser D.E., Pittet M.J., Valmori D., Dunbar R., Rimoldi D., Lienard D., MacDonald H.R., Cerottini J.-C., Cerundolo V., Romero P. In vivo expression of natural killer inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. M. 190:1999;775-782.
57. + T cells. J. Virol. 74:2000;1018-1022.
58. Buller R.M., Holmes K.L., Hugin A., Frederickson T.N., Morse III H.C. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature. 328:1987;77-79.
59. Rahemtulla A., Kundig T.M., Narendran A., Bachmann M.F., Julius M., Paige C.J., Ohashi P., Zinkernagel R.M., Mak T.W. Class II major histocompatibility complex-restricted T-cell function in CD4-deficient mice. Eur. J. Immunol. 24:1994;2213-2218.
60. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:1988;2102-2106.
61. Leist T.P., Kohler M., Zinkernagel R.M. Impaired generation of anti-viral cytotoxicity against lymphocyte choriomeningitis and vaccinia virus in mice treated with CD4-secific monoclonal antibody. Scand. J. Immunol. 1989;679-686.
62. Kast W.M., Bronkhorst A.M., de Waal L.P., Melief C.J.M. Co-operation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. J. Exp. M. 164:1986;723-738.
63. Zinkernagel R.M., Callahan G.N., Althage A., Cooper S., Streilein J.W., Klein J. The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T cell help. J. Exp. M. 147:1978;897-911.
64. Lee P.P., Yee C., Savage P.A., Fong L., Brockstedt D., Weber J.S., Johnson D., Swetter S., Thompson J., Greenberg P.D., Roederer M., Davis M.M. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. M. 5:1999;677-685.
65. Phillips J.H., Gumperz J.E., Parham P., Lanier L.L. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science. 268:1995;2294-2298.
66. Noppen C., Schaefer C., Zajac P., Schutz A., Kocher T., Kloth J., Heberer M., Colonna M., De Libero G., Spagnoli G.C. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity. Eur. J. Immunol. 28:1998;1134-1142.
67. Moser J.M., Altman J.D., Lukacher A.E., Antiviral C.D. T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function. J. Exp. M. 193:2001;595-605.
68. Spencer J.V., Braciale T.J., Incomplete C.D. T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. J. Exp. M. 191:2000;1687-1698.
69. + T cells by HLA-DR1 oligomers is dependent on the T cell activation state. J. Immunol. 166:2001;741-745.
70. Fahmy T.M., Bieler J.G., Edidin M., Schneck J.P. Increased TCR avidity after T-cell activation: a mechanism for sensing low-density antigen. Immunity. 14:2001;135-143.